1. Home
  2. IQV vs XYL Comparison

IQV vs XYL Comparison

Compare IQV & XYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$168.96

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Logo Xylem Inc. New

XYL

Xylem Inc. New

HOLD

Current Price

$129.66

Market Cap

29.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQV
XYL
Founded
1982
2011
Country
United States
United States
Employees
93000
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.6B
29.2B
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
IQV
XYL
Price
$168.96
$129.66
Analyst Decision
Strong Buy
Buy
Analyst Count
16
12
Target Price
$227.13
$155.55
AVG Volume (30 Days)
1.2M
1.8M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
1.34%
EPS Growth
4.67
7.40
EPS
7.84
3.92
Revenue
$9,739,000,000.00
$9,035,000,000.00
Revenue This Year
$6.78
$2.91
Revenue Next Year
$5.88
$4.51
P/E Ratio
$22.03
$32.68
Revenue Growth
41.60
5.52
52 Week Low
$134.65
$105.73
52 Week High
$247.05
$154.27

Technical Indicators

Market Signals
Indicator
IQV
XYL
Relative Strength Index (RSI) 44.69 62.08
Support Level $159.42 $123.98
Resistance Level $170.89 $132.86
Average True Range (ATR) 6.19 2.92
MACD 1.31 1.51
Stochastic Oscillator 36.04 99.19

Price Performance

Historical Comparison
IQV
XYL

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About XYL Xylem Inc. New

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $9 billion in revenue in 2025.

Share on Social Networks: